National Cancer Institute Opens First Therapeutic Vaccine Trial for Chordoma Patients
The National Cancer Institute has expanded an ongoing Phase I clinical trial of a therapeutic vaccine targeting the brachyury protein … Continue reading
The National Cancer Institute has expanded an ongoing Phase I clinical trial of a therapeutic vaccine targeting the brachyury protein … Continue reading
Following the Fourth International Chordoma Research Workshop, letters of intent poured in with new ideas and potential collaborations that researchers … Continue reading
Last month, doctors, scientists, patients and family members from around the world gathered in Boston for the Fourth International Chordoma … Continue reading
Whether a patient, family member, volunteer, donor, physician, or researcher, our connection to chordoma makes us uncommon in what we make of … Continue reading
Dr. Tom DeLaney of Massachusetts General Hospital is leading a new Phase II study that will utilize the newest technology … Continue reading
Chordoma Foundation Executive Director, Josh Sommer, has been named by Forbes to its list of “30 Under 30,” 30 individuals … Continue reading
The newest member of the Chordoma Foundation’s growing team, Patty Cogswell brings over 25 years of cancer research experience to … Continue reading
Foundation-funded research yields major discovery that could open door to new therapies For the first time ever, scientists have identified … Continue reading
Researchers at Johns Hopkins Hospital are testing a new cancer treatment that uses bacteria to kill tumors, and chordoma may … Continue reading
We are pleased to announce that registration is open for the Fourth Chordoma Community Conference, which will be held from … Continue reading